HomeProductsBioactive CompoundsAnti-Infective AgentsAntibacterial AgentsTrimetrexate
Chemical structure of CAS 52128-35-5

Trimetrexate

In Stock•Starting at $100 for 10 mg•Purity ≥ 98%
CAS No.52128-35-5
MDL No.MFCD00866404
MFC19H23N5O3
MW369.40
InChI KeyNOYPYLRCIDNJJB-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg98%$100In Stock
25 mg98%$186In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Trimetrexate is a quinazoline derivative with antifungal activity.

CAS No.52128-35-5
Product NameTrimetrexate

Associated Conditions

sarcoma·amebiasis·colorectal cancer·pneumocystosis·pancreatic carcinoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Acute graft-vs-host disease: pathobiology and management.

Experimental hematology • Vol. 29, Issue 3 • 2001
PMID: 11274753DOI: 10.1016/s0301-472x(00)00677-9

Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells.

Biochemical pharmacology • Vol. 61, Issue 7 • 2001
PMID: 11274972DOI: 10.1016/s0006-2952(01)00532-9

A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.

Archives of internal medicine • Vol. 161, Issue 12 • 2001
PMID: 11427101DOI: 10.1001/archinte.161.12.1529

Design, synthesis, computational prediction, and biological evaluation of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii.

Journal of medicinal chemistry • Vol. 44, Issue 15 • 2001
PMID: 11448221DOI: 10.1021/jm010856u

Documentation

Similar Products